diabetic retinopathy

Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug
Clinical Trials Arena
Tue, 05/14/24 - 11:27 am
Kodiak Sciences
clinical trials
tarcocimab tedromer
diabetic retinopathy
AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy
Pharma Voice
Wed, 04/24/24 - 08:42 am
Regenxbio
AbbVie
gene therapy
ABBV-RGX-314
wet age-related macular degeneration
diabetic retinopathy
Regenxbio unveils positive data from diabetic retinopathy therapy trial
Clinical Trials Arena
Mon, 11/6/23 - 11:27 am
Regenxbio
clinical trials
ABBV-RGX-314
diabetic retinopathy
Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific
Fierce Biotech
Thu, 10/19/23 - 11:36 am
Roche
diabetic retinopathy
solid tumors
bispecific antibodies
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
Motley Fool
Mon, 09/11/23 - 06:36 pm
Eyepoint
clinical trials
EYP-1901
diabetic retinopathy
Ocuphire still focused on FDA approval despite diabetic eye drug missing phase 2 endpoint
Fierce Biotech
Thu, 01/26/23 - 10:39 am
Ocuphire Pharma
diabetic retinopathy
clinical trials
APX3330
Eyenuk raises $26M for diabetic retinopathy screening tech
MedCity News
Tue, 10/18/22 - 10:49 am
Eyenuk
diagnostics
funding
diabetes
diabetic retinopathy
Low-profile eye drop developer spells out the game plan that drew Brent Saunders to the board — and it involves going earlier than anti-VEGFs
Endpoints
Tue, 11/9/21 - 10:43 am
OcuTerra
diabetic retinopathy
wet age-related macular degeneration
Brent Saunders
Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data
Fierce Pharma
Fri, 04/2/21 - 10:55 am
Regeneron
FDA
Eylea
diabetic retinopathy
NIH
Verana strikes research collaboration with Janssen on ophthalmology and urology
MedCity News
Wed, 01/27/21 - 08:02 pm
Verana Health
JNJ
Janssen
data analytics
diabetic retinopathy
diabetic macular edema
10 New Ways Medtech Could Keep Diabetes in Check
Medical Devices and Diagnostics Industry
Mon, 11/25/19 - 09:42 am
diabetes
devices
Pavmed
diabetic retinopathy
Medios AI
DexCom
Aerami Therapeutics
Brighter
Actise
continuous glucose monitoring
Valeritas
Abbott Labs
Enable Biosciences
Roche AI Program Can Predict Progression of Diabetic Retinopathy
BioSpace
Tue, 09/24/19 - 07:11 pm
artificial intelligence
Roche
Genentech
diabetic retinopathy
deep learning
FDA approves Regeneron’s Eylea for diabetic retinopathy
Pharmaforum
Tue, 05/14/19 - 09:58 am
Regeneron
Eylea
diabetic retinopathy
FDA
Bayer
Regeneron and Roche Duke it Out in the Diabetic Retinopathy Market
BioSpace
Thu, 10/25/18 - 11:43 am
Regeneron
Eylea
diabetic retinopathy
Roche
Lucentis
FDA to review Regeneron’s Eylea for diabetic retinopathy
Drug Delivery Business News
Thu, 09/13/18 - 11:29 pm
Regeneron
FDA
Eylea
diabetic retinopathy
How AI can diagnose a leading cause of blindness
Medical Design and Outsourcing
Thu, 08/30/18 - 10:18 am
artificial intelligence
diabetic retinopathy
devices
IDx-DR
IDx
Regeneron Focuses on Expanding Eylea’s Diabetic Retinopathy Label
Market Realist
Thu, 06/21/18 - 09:38 am
Regeneron
FDA
Eylea
diabetic retinopathy
FDA approves first AI-powered device to detect diabetic retinopathy
Drug Delivery Business News
Wed, 04/11/18 - 11:28 pm
artificial intelligence
devices
diabetic retinopathy
FDA
IDx
IDx-DR
Regeneron’s Eylea Shows Promise in Late-Stage Diabetic Retinopathy Trial
Xtalks
Tue, 03/20/18 - 09:45 am
Regeneron
Eylea
diabetic retinopathy
Diabetic Retinopathy Could Soon be Diagnosed by AI System
Xtalks
Tue, 02/27/18 - 10:42 pm
diabetes
diabetic retinopathy
artificial intelligence
diagnostics
IDx

Pages